Current Report Filing (8-k)
October 22 2014 - 6:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 21, 2014
CEL-SCI CORPORATION
(Exact name of registrant as specified in its charter)
Colorado 001-11889 84-0916344
------------------------- ------------------ -----------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
8229 Boone Blvd. #802
Vienna, VA 22182
----------------------------------------
(Address of principal executive offices, including Zip Code)
|
Registrant's telephone number, including area code: (703) 506-9460
N/A
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:
[] Written communications pursuant to Rule 425 under the Securities Act
(17CFR 230.425)
[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)
[] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-14c))
Item 1.01 Entry Into a Material Definitive Agreement.
On October 21, 2014, CEL-SCI Corporation (the "Company"), sold 1,320,000
shares of the Company's common stock, as well as warrants to purchase an
additional 330,000 shares of common stock. For every four shares sold, the
Company will issue to investors in this offering one warrant. The warrants are
immediately exercisable, expire October 11, 2018 and have an exercise price of
$1.25. The warrants are traded on the NYSE MKT under the symbol "CVM WS". The
shares of common stock and warrants are being sold at a combined price of $0.76
per share and quarter warrant, minus sales commission. The common stock and
warrants will separate immediately. The offering is expected to close on or
about October 24, 2014, subject to customary closing conditions.
The net proceeds from the offering are expected to be approximately
$928,000, after deducting the sales and commissions and estimated expenses
payable by the Company.
The offering is being made pursuant to the Registration Statement and
Prospectus Supplement discussed below under Item 8.01. A copy of the opinion of
Hart & Hart, LLC relating to the legality of the issuance and sale of the shares
and warrants in the offering is attached as Exhibit 5 hereto.
On October 21, 2014, the Company issued a press release announcing that it
had priced the offering. A copy of the press release is attached hereto as
Exhibit 99.1.
Item 8.01 Other Events.
On October 21, 2014, the Company filed with the Securities Exchange
Commission (the "Commission") a prospectus supplement (the "Prospectus
Supplement") to the prospectus (the "Prospectus") included as part of the
Company's registration statement on Form S-3 declared effective by the
Commission on July 8, 2014 (File No. 333-196243) (the "Registration Statement"),
pursuant to which the Company will sell, in a registered direct offering,
1,320,000 shares of the Company's common stock, as well as warrants to purchase
an additional 330,000 shares of common stock.
Prospective investors should read the Registration Statement, the
Prospectus dated July 8, 2014, and the Prospectus Supplement, and all documents
incorporated by reference by the foregoing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Description
4 Terms of Warrants
5 Opinion of Hart & Hart, LLC
23 Consent of Hart & Hart, LLC
99.1 Press Release dated October 21, 2014.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 21, 2014
CEL-SCI CORPORATION
By: /s/ Patricia B. Prichep
----------------------------------
Patricia B. Prichep
Senior Vice President of Operations
|
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Sep 2023 to Sep 2024